Cuero Diabetes Support Group

01/11/2026

In a phase II human clinical trial published in Clinical Cancer Research (2008) by Dhillon et al., researchers investigated high-dose oral curcumin (8 grams per day) in 21 patients with advanced, treatment-resistant pancreatic cancer. These were patients who had already failed standard therapies. Tumor response was monitored using imaging every few months while patients continued curcumin until disease progression.
The results showed biological activity in two patients. One patient experienced stable disease for more than 18 months, which is rare in advanced pancreatic cancer.

Another patient showed a brief but dramatic ~73% reduction in measurable tumor size before progression resumed. Blood analysis in this responder showed large changes in inflammatory and immune markers, confirming curcumin was biologically active in humans. Importantly, no dose-limiting toxicity or serious side effects were reported, even at this very high dose, which is why curcumin continues to be studied as a potential supportive or adjunct therapy, not a standalone cancer treatment.

PMID: 34572272

01/09/2026

01/08/2026

This MRI doesn’t just detect tumours, it eradicates them without a single incision.

Doctors in Sydney are now using an advanced MRI-guided system that freezes tumours from the inside out. No cutting, no stitches, no operating room, just real-time imaging and a freezing instrument that turns cancer cells into ice and stops them.

Patients arrive, have the tumour targeted with exact precision, watch as it’s frozen under MRI guidance, and leave the same day without pain, scars, or a hospital stay.

This method, called cryoablation, destroys the tumour while protecting the healthy tissue around it, something traditional surgery has never been able to match. For people too fragile for surgery or carrying tumours in risky areas, it offers a real second chance.

Cryoablation can reach temperatures of –40°C or lower, rupturing malignant cells while keeping nearby structures intact. A reminder that some of the biggest advances in cancer care come from smarter techniques, not larger operations.

Save this for later.

01/05/2026

01/05/2026

OLIVE OIL COMPOUND KILLS CANCER CELLS 🫒🛑
It destroyed the tumor cells in minutes while sparing the healthy ones...

A powerful compound found in 𝗲𝘅𝘁𝗿𝗮 𝘃𝗶𝗿𝗴𝗶𝗻 𝗼𝗹𝗶𝘃𝗲 𝗼𝗶𝗹 called 𝗼𝗹𝗲𝗼𝗰𝗮𝗻𝘁𝗵𝗮𝗹 is stunning researchers with its ability to target cancer. In lab tests, when applied directly to cancer cells, the molecule caused them to break down and self-destruct within just 𝟯𝟬 𝗺𝗶𝗻𝘂𝘁𝗲𝘀.

Unlike traditional chemotherapy, which attacks both good and bad cells, this natural substance acts with surgical precision. It works by puncturing the cancer cell's 𝗹𝘆𝘀𝗼𝘀𝗼𝗺𝗲𝘀—their internal waste disposal system—triggering a total collapse from the inside. Remarkably, the surrounding 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝗰𝗲𝗹𝗹𝘀 remained completely 𝘂𝗻𝗵𝗮𝗿𝗺𝗲𝗱 during the process.

While scientists are still studying how this translates to living organisms, the implications are massive. This discovery suggests that future cancer treatments could be faster, safer, and based on 𝗻𝗮𝘁𝘂𝗿𝗮𝗹 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 rather than harsh chemicals or radiation. It turns a common kitchen staple into a potential medical breakthrough.

Why it Matters: Finding treatments that target cancer without poisoning the patient is the "Holy Grail" of oncology, and this research suggests the answer might be hiding in nature.

Debate: Should we invest more funding into researching natural food cures compared to synthetic pharmaceutical drugs?

12/25/2025

12/25/2025

A new peptide-based nasal spray is drawing serious attention in neuroscience research after studies showed it may help reverse key brain changes linked to Alzheimer’s disease. In controlled laboratory studies, researchers found that this experimental spray helped repair damaged neural connections and significantly improved memory performance in animal models affected by Alzheimer’s-like symptoms.

The treatment works by delivering therapeutic peptides directly through the nasal passage, allowing them to bypass the blood brain barrier. This direct route helps the peptides reach brain tissue more efficiently, where they appear to reduce toxic protein buildup, protect neurons, and restore communication between brain cells. These processes are critical because Alzheimer’s is strongly associated with synaptic loss, inflammation, and disrupted signaling in memory related regions of the brain.

What makes this discovery especially important is that current Alzheimer’s treatments mainly slow symptom progression rather than repairing damage. In contrast, this peptide approach focuses on restoring brain function at the cellular level. Researchers observed improved learning ability and memory recall in treated subjects, suggesting that lost cognitive functions may not be permanently gone, at least in early stages of the disease.

It is important to note that this therapy is still in the research phase and has not yet been approved for human use. Clinical trials are still required to confirm safety, dosage, and effectiveness in people. However, the findings are peer reviewed and grounded in real neuroscience, not speculation.

As Alzheimer’s cases continue to rise worldwide, innovations like peptide nasal delivery offer a realistic and science-backed path toward better treatments. This research marks a hopeful step toward future therapies that do more than manage symptoms and instead help the brain heal itself.